Edwards Lifesciences Corp financial data

Symbol
EW on NYSE
Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 25 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 417% % 11%
Quick Ratio 73% % -4.7%
Debt-to-equity 29% % -13%
Return On Equity 10% % -79%
Return On Assets 8% % -78%
Operating Margin 21% % -18%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 580,800,000 shares -1.2%
Common Stock, Shares, Outstanding 580,700,000 shares -1.3%
Entity Public Float $45,899,189,298 USD -17%
Common Stock, Value, Issued $658,700,000 USD 0.6%
Weighted Average Number of Shares Outstanding, Basic 584,800,000 shares -2.2%
Weighted Average Number of Shares Outstanding, Diluted 585,800,000 shares -2.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $6,067,600,000 USD 12%
Research and Development Expense $1,079,200,000 USD 2.5%
Operating Income (Loss) $1,264,200,000 USD -8.3%
Nonoperating Income (Expense) $8,700,000 USD -95%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,272,900,000 USD -18%
Income Tax Expense (Benefit) $216,900,000 USD 43%
Net Income (Loss) Attributable to Parent $1,073,500,000 USD -74%
Earnings Per Share, Basic 1.84 USD/shares -74%
Earnings Per Share, Diluted 1.83 USD/shares -74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,938,000,000 USD -3.5%
Accounts Receivable, after Allowance for Credit Loss, Current $659,600,000 USD 8.3%
Inventory, Net $1,126,200,000 USD 3.6%
Other Assets, Current $339,300,000 USD -2.4%
Assets, Current $6,738,900,000 USD 7.2%
Deferred Income Tax Assets, Net $1,138,100,000 USD 15%
Property, Plant and Equipment, Net $1,811,900,000 USD 7.5%
Operating Lease, Right-of-Use Asset $102,700,000 USD 4.6%
Intangible Assets, Net (Excluding Goodwill) $1,128,200,000 USD -4.1%
Goodwill $1,768,600,000 USD -0.46%
Other Assets, Noncurrent $730,200,000 USD 1.2%
Assets $13,697,200,000 USD 4.9%
Accounts Payable, Current $227,500,000 USD 15%
Employee-related Liabilities, Current $467,500,000 USD 30%
Liabilities, Current $1,813,700,000 USD 20%
Operating Lease, Liability, Noncurrent $82,600,000 USD 4.7%
Other Liabilities, Noncurrent $362,300,000 USD -2.9%
Liabilities $3,359,600,000 USD 12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $238,300,000 USD 2.5%
Retained Earnings (Accumulated Deficit) $14,240,500,000 USD 8.2%
Stockholders' Equity Attributable to Parent $10,337,600,000 USD 3.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $10,337,600,000 USD 2.7%
Liabilities and Equity $13,697,200,000 USD 4.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $280,400,000 USD
Net Cash Provided by (Used in) Financing Activities $258,000,000 USD -518%
Net Cash Provided by (Used in) Investing Activities $85,300,000 USD 35%
Common Stock, Shares Authorized 1,050,000,000 shares 0%
Common Stock, Shares, Issued 658,700,000 shares 0.6%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $90,000,000 USD 11%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,939,500,000 USD -3.9%
Deferred Tax Assets, Valuation Allowance $104,100,000 USD 19%
Deferred Tax Assets, Gross $1,506,800,000 USD 12%
Operating Lease, Liability $107,100,000 USD 4.7%
Payments to Acquire Property, Plant, and Equipment $56,000,000 USD -14%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,079,700,000 USD -74%
Lessee, Operating Lease, Liability, to be Paid $130,900,000 USD 15%
Property, Plant and Equipment, Gross $2,661,700,000 USD 7.3%
Operating Lease, Liability, Current $24,500,000 USD 4.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two $23,300,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $28,300,000 USD 7.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $23,800,000 USD 100%
Lessee, Operating Lease, Liability, to be Paid, Year Three $18,200,000 USD -4.7%
Deferred Tax Assets, Operating Loss Carryforwards $143,500,000 USD 8.6%
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $767,400,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year Four $11,300,000 USD -14%
Operating Lease, Payments $7,000,000 USD -4.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $36,600,000 USD -4.9%
Share-based Payment Arrangement, Expense $157,900,000 USD 8.4%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%